Ontology highlight
ABSTRACT:
SUBMITTER: Markussen A
PROVIDER: S-EPMC7409144 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
Markussen Alice A Jensen Lars Henrik LH Diness Laura Vittrup LV Larsen Finn Ole FO
Cancers 20200720 7
This study is an investigator-initiated randomized phase II trial focusing on the treatment of advanced biliary tract cancer with either oxaliplatin 50 mg/m<sup>2</sup> and gemcitabine 1000 mg/m<sup>2</sup> on day 1 in a two-week cycle with capecitabine 650 mg/m<sup>2</sup> twice-daily continuously or cisplatin 25 mg/m<sup>2</sup> and gemcitabine 1000 mg/m<sup>2</sup> on day 1 and day 8 in a three-week cycle. One-hundred patients were included. Forty-seven patients received oxaliplatin, gemcitab ...[more]